Studying at the University of Verona

Study Plan

Queste informazioni sono destinate esclusivamente agli studenti e alle studentesse già iscritti a questo corso.
Se sei un nuovo studente interessato all'immatricolazione, trovi le informazioni sul percorso di studi alla pagina del corso:

Laurea magistrale a ciclo unico in Medicina e chirurgia - Immatricolazione dal 2025/2026.

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

1° Year

ModulesCreditsTAFSSD
6
A
BIO/16
6
A
BIO/13
15
A
BIO/10
9
A/B
FIS/07 ,MED/01
5
B
L-LIN/12
9
B
BIO/17
2
D
-

2° Year  activated in the A.Y. 2014/2015

ModulesCreditsTAFSSD
12
A
BIO/16
15
A/B
BIO/11 ,BIO/13 ,MED/03
9
B
MED/04
6
B
L-LIN/12
9
B/F
- ,MED/02 ,M-PSI/08 ,SPS/07
2
D
-

3° Year  activated in the A.Y. 2015/2016

ModulesCreditsTAFSSD
4
B
BIO/14
9
A/C
BIO/09
12
A
BIO/09 ,M-PSI/01
9
B
MED/07
17
B
MED/04 ,MED/09
2
D
-

4° Year  activated in the A.Y. 2016/2017

ModulesCreditsTAFSSD
6
B
MED/28 ,MED/30 ,MED/31
5
B/C
BIO/14
14
B/C/F
- ,BIO/12 ,MED/09 ,MED/18
23
B/F
- ,MED/08 ,MED/12 ,MED/15 ,MED/16 ,MED/17 ,MED/35
18
B/F
- ,MED/08 ,MED/10 ,MED/11 ,MED/13 ,MED/14 ,MED/21 ,MED/22 ,MED/23
1
D
-

5° Year  activated in the A.Y. 2017/2018

ModulesCreditsTAFSSD
6
B
MED/08
7
B
MED/06 ,MED/18 ,MED/33
12
B/F
- ,MED/18 ,MED/24
6
B
MED/36
10
B/C/F
- ,MED/09
7
B
MED/26 ,MED/27 ,MED/34
6
B
MED/25
9
B
MED/42 ,MED/43 ,MED/44
1
D
-

6° Year  activated in the A.Y. 2018/2019

ModulesCreditsTAFSSD
24
B/F
- ,MED/09 ,MED/45
8
B/C
MED/09 ,MED/18 ,MED/41
9
B/F
- ,MED/40
12
B/F
- ,MED/20 ,MED/38 ,MED/39
Prova finale
18
E
-
activated in the A.Y. 2014/2015
ModulesCreditsTAFSSD
12
A
BIO/16
15
A/B
BIO/11 ,BIO/13 ,MED/03
9
B
MED/04
6
B
L-LIN/12
9
B/F
- ,MED/02 ,M-PSI/08 ,SPS/07
2
D
-
activated in the A.Y. 2016/2017
ModulesCreditsTAFSSD
6
B
MED/28 ,MED/30 ,MED/31
5
B/C
BIO/14
14
B/C/F
- ,BIO/12 ,MED/09 ,MED/18
23
B/F
- ,MED/08 ,MED/12 ,MED/15 ,MED/16 ,MED/17 ,MED/35
18
B/F
- ,MED/08 ,MED/10 ,MED/11 ,MED/13 ,MED/14 ,MED/21 ,MED/22 ,MED/23
1
D
-
activated in the A.Y. 2017/2018
ModulesCreditsTAFSSD
6
B
MED/08
7
B
MED/06 ,MED/18 ,MED/33
12
B/F
- ,MED/18 ,MED/24
6
B
MED/36
10
B/C/F
- ,MED/09
7
B
MED/26 ,MED/27 ,MED/34
6
B
MED/25
9
B
MED/42 ,MED/43 ,MED/44
1
D
-
activated in the A.Y. 2018/2019
ModulesCreditsTAFSSD
24
B/F
- ,MED/09 ,MED/45
8
B/C
MED/09 ,MED/18 ,MED/41
9
B/F
- ,MED/40
12
B/F
- ,MED/20 ,MED/38 ,MED/39
Prova finale
18
E
-

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.

A Basic activities
B Characterizing activities
C Related or complementary activities
D Activities to be chosen by the student
E Final examination
F Other training activities
S Placements in companies, public or private institutions and professional associations

Clinical Pharmacology  (2016/2017)

Teaching code

4S001431

Teacher

Guido Francesco Fumagalli

Coordinator

Guido Francesco Fumagalli

Credits

5

Language

Italian

Scientific Disciplinary Sector (SSD)

BIO/14 - PHARMACOLOGY

Period

Lezioni 1° semestre 2°- 6° anno dal Oct 3, 2016 al Dec 22, 2016.

Location

VERONA

Seminars 0

Learning outcomes

This course is an expansion/continuation of the General Pharnmacology course. By completing this course, the student will:
- Know the properties (mechanisms of action, clinical effects, pharmacokinetics, therapeutic uses, adverse reactions) of classes of drugs active on: cardiovascular, central and peripheral, endocrine, and gastrointestinal systems and acting on inflammatory processes.
- Be able to define the rationale for the selection and use of drug in relation to the undergoing pathology, the characteristics and the clinical state of the patient and the evidences available on the scientific literature
- Know how to monitor the efficacy of the therapy and recognize the occurrence of adverse reactions.

Program

The programme of the course is focussed on the analysis of drug properties (mechanism of action, clinical effects, therapeutic use, adverse reaction). Specifically, for each class of drugs, the student will:
Know the level of evidence and the classification of recommendation as defined by the scientific literature and the referring medical scientific association
Recognize the efficacy of a drug/therapy based on positive symptoms elicited and the occurrence of adverse reactions
Construct the rationale for the therapeutic choices based on the properties of drugs actives on cardiovascular, central and peripheral, endocrine, and gastrointestinal systems and acting on inflammatory processes.
Know how to use manuals and write prescriptions
Be able to critically understand design and results of clinical trials
The classes of drugs that will be considered are the following:
Drugs active on cardiovascular system
Drugs active on Central and Peripheral Nervous system
Drugs active on gastrointestinal tract
Drugs for the control of dislipidemia
Oral antidiabetic drugs
Drugs active on inflammatory processes

Reference texts
Author Title Publishing house Year ISBN Notes
Bertram G. Katzung Basic and Clinical Pharmacology (Edizione 13) McGraw-Hill Education 2015 978-0-07-182505-3
B. G. Katzung & A. J. Trevor Farmacologia Generale e Clinica (Edizione 10) Piccin-Nuova Libraria 2017 978-88-299-2847-7
Goodman & Gilman The pharmacological basis of therapeutics (Edizione 13) McGraw-Hill Education 2017 9780071624428

Examination Methods

Oral examination
The student will be asked to describe the properties of classes of drugs, mentioning the mechanisms of action, the clinical effects, the therpeutic indication; the limits of the therapy and the most relevat adverse reactions;, the criteria of selection between drugs of a same classe or between different classes

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE